mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.07 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.07 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.07 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.07 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.08 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.08 |